Skip to main navigation Skip to search Skip to main content

LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL

  • N. Ruperto
  • , H. I. Brunner
  • , P. Quartier
  • , T. Constantin
  • , E. Alexeeva
  • , R. Schneider
  • , I. Kone-Paut
  • , K. Schikler
  • , K. Marzan
  • , N. Wulffraat
  • , S. Padeh
  • , V. Chasnyk
  • , C. Wouters
  • , J. B. Kuemmerle-Deschner
  • , T. Kallinich
  • , B. Lauwerys
  • , E. Haddad
  • , E. Nasonov
  • , M. Trachana
  • , O. Vougiouka
  • K. Leon, A. Speziale, K. Lheritier, A. Martini, D. Lovell

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)265-266
JournalAnnals of the Rheumatic Diseases
Volume75
DOIs
Publication statusPublished - Jun 2016

Cite this